West Pharmaceutical Services Inc financial data

Symbol
WST on NYSE
Industry
Surgical & Medical Instruments & Apparatus
Location
530 Herman O. West Drive, Exton, Pennsylvania
State of incorporation
Pennsylvania
Fiscal year end
December 31
Former names
WEST CO INC (to 2/11/1999)
Latest financial report
Q1 2024 - Apr 25, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 316 % -10.9%
Quick Ratio 73.8 % -9.16%
Debt-to-equity 32.9 % -6.9%
Return On Assets 15.3 % -2.79%
Operating Margin 25.4 % -4.29%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 72.8M shares -1.89%
Common Stock, Shares, Outstanding 73M shares -1.62%
Entity Public Float 28.2B USD +26.5%
Common Stock, Value, Issued 18.8M USD 0%
Weighted Average Number of Shares Outstanding, Basic 73.5M shares -1.34%
Weighted Average Number of Shares Outstanding, Diluted 74.3M shares -1.85%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 695M USD -2.96%
Revenue from Contract with Customer, Excluding Assessed Tax 2.93B USD +1.56%
Research and Development Expense 68.9M USD +13%
Operating Income (Loss) 644M USD -8.02%
Nonoperating Income (Expense) 24M USD +76.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 185M USD -18.6%
Income Tax Expense (Benefit) 115M USD -1.71%
Net Income (Loss) Attributable to Parent 569M USD +3.01%
Earnings Per Share, Basic 7.67 USD/shares +3.51%
Earnings Per Share, Diluted 7.58 USD/shares +3.98%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 602M USD -32.1%
Accounts Receivable, after Allowance for Credit Loss, Current 524M USD +2.07%
Inventory, Net 430M USD -3.83%
Other Assets, Current 137M USD +51.6%
Assets, Current 1.69B USD -12.6%
Deferred Income Tax Assets, Net 21M USD -78.8%
Property, Plant and Equipment, Net 1.45B USD +19.2%
Operating Lease, Right-of-Use Asset 96.8M USD -4.25%
Intangible Assets, Net (Excluding Goodwill) 13.9M USD -21.9%
Goodwill 108M USD -0.19%
Other Assets, Noncurrent 19M USD -48.2%
Assets 3.6B USD -3.26%
Accounts Payable, Current 240M USD +2.7%
Liabilities, Current 648M USD +21.2%
Deferred Income Tax Liabilities, Net 12.7M USD -12.4%
Operating Lease, Liability, Noncurrent 82.4M USD -8.34%
Other Liabilities, Noncurrent 57.9M USD +3.76%
Liabilities 922M USD -2.71%
Accumulated Other Comprehensive Income (Loss), Net of Tax -192M USD -14.2%
Retained Earnings (Accumulated Deficit) 3.62B USD +16.4%
Stockholders' Equity Attributable to Parent 2.68B USD -3.44%
Liabilities and Equity 3.6B USD -3.26%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 118M USD -14.4%
Net Cash Provided by (Used in) Financing Activities -271M USD -282%
Net Cash Provided by (Used in) Investing Activities -90.6M USD -10.4%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 75.3M shares 0%
Common Stock, Par or Stated Value Per Share 0.25 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -252M USD -3051%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 602M USD -32.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 6M USD -9.09%
Deferred Tax Assets, Valuation Allowance 15.5M USD +16.5%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability 100M USD -5.37%
Depreciation 34.7M USD +13%
Payments to Acquire Property, Plant, and Equipment 90.6M USD +10.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 545M USD -3.76%
Lessee, Operating Lease, Liability, to be Paid 116M USD -6.09%
Property, Plant and Equipment, Gross 2.79B USD +12.6%
Operating Lease, Liability, Current 18M USD +11.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 16.5M USD +1.85%
Lessee, Operating Lease, Liability, to be Paid, Year One 19.5M USD +6.56%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) 37.5M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 15.3M USD -10.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 11.9M USD -11.2%
Deferred Tax Assets, Operating Loss Carryforwards 10M USD -2.91%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) 84.8M USD -41.7%
Preferred Stock, Shares Authorized 3M shares 0%
Unrecognized Tax Benefits 38.8M USD +6.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 10.1M USD +8.6%
Operating Lease, Payments 19.5M USD +30%
Additional Paid in Capital 55.2M USD -69.6%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) -4.2M USD -150%
Current Federal Tax Expense (Benefit) 30.2M USD -60.1%
Amortization of Intangible Assets 3.6M USD -2.7%
Depreciation, Depletion and Amortization 137M USD +13.8%
Deferred Tax Assets, Net of Valuation Allowance 98.2M USD -24.9%
Share-based Payment Arrangement, Expense 19.8M USD -25.8%
Interest Expense 8.4M USD +6.33%